This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Albert-Ludwigs-Universitat Freiburg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2020.
Company Filing History:
1 out of 94 
1 out of 166 
Years Active: 2020
Title: Max Schelker: Innovator in Anemia Treatment
Introduction
Max Schelker is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of anemia. His innovative approach focuses on optimizing the dosage of erythropoiesis stimulating agents (ESA) for patients suffering from this condition.
Latest Patents
Max Schelker holds a patent for "Methods for the prediction of a personalized ESA-dose in the treatment of anemia." This invention features an integrative pharmacokinetic/pharmacodynamics (PK/PD) ESA-EpoR mathematical model that calculates the binding behavior of ESAs. The methods provided enable clinical practitioners to determine ESA binding sites in patients, which is crucial for optimizing treatment regimens, especially in cancer patients. Additionally, the patent includes methods for screening ESAs that exhibit higher specificity for cells expressing the EPO receptor, such as colony forming units-erythroid (CFU-E) cells.
Career Highlights
Throughout his career, Max Schelker has worked with esteemed institutions, including the Deutsches Krebsforschungszentrum and Albert-Ludwigs-Universität Freiburg. His work has been instrumental in advancing the understanding of anemia treatment and improving patient outcomes.
Collaborations
Max has collaborated with notable professionals in his field, including Andreas Raue and Agustin Rodriguez Gonzalez. Their combined expertise has contributed to the development of innovative solutions in anemia treatment.
Conclusion
Max Schelker's contributions to the medical field, particularly in anemia treatment, highlight his innovative spirit and dedication to improving patient care. His patent and collaborative efforts reflect a commitment to advancing medical science and enhancing treatment methodologies.